Vitamin C and L-Proline Antagonistic Effects Capture Alternative States in the Pluripotency Continuum by D'Aniello, C. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/165841
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Stem Cell Reports
Report
Vitamin C and L-Proline Antagonistic Effects Capture Alternative States in the
Pluripotency Continuum
Cristina D’Aniello,1 Ehsan Habibi,2 Federica Cermola,1 Debora Paris,3 Francesco Russo,4
Alessandro Fiorenzano,1 Gabriele Di Napoli,1 Dominique J. Melck,3 Gilda Cobellis,5 Claudia Angelini,4
Annalisa Fico,1 Robert Blelloch,6 Andrea Motta,3 Hendrik G. Stunnenberg,2 Dario De Cesare,1,*
Eduardo J. Patriarca,1 and Gabriella Minchiotti1,*
1Stem Cell Fate Laboratory, Institute of Genetics and Biophysics, ’A. Buzzati-Traverso’, CNR, 80131 Naples, Italy
2Department of Molecular Biology, Radboud University, Faculty of Science, Radboud Institute for Molecular Life Sciences, 6525 GA Nijmegen, the
Netherlands
3Institute of Biomolecular Chemistry, CNR, 80078 Pozzuoli (Napoli), Italy
4Institute for Applied Mathematics ‘‘Mauro Picone’’, CNR, 80131 Naples, Italy
5Department of Biophysics, Biochemistry and General Pathology, Second University of Naples, 80138 Naples, Italy
6Department of Urology, The Eli and Edythe Broad Center of RegenerationMedicine and StemCell Research, Center for Reproductive Sciences, University of
California, San Francisco, San Francisco, CA 94143, USA
*Correspondence: dario.decesare@igb.cnr.it (D.D.C.), gabriella.minchiotti@igb.cnr.it (G.M.)
http://dx.doi.org/10.1016/j.stemcr.2016.11.011
SUMMARY
Metabolites and cofactors are emerging as key regulators of cell plasticity and reprogramming, and their role in the control of pluripo-
tency is just being discovered.Herewe provide unprecedented evidence that embryonic stem cell (ESC) pluripotency relies on the relative
levels of two physiological metabolites, namely ascorbic acid (vitamin C, VitC) and L-proline (L-Pro), which affect global DNA methyl-
ation, transcriptional profile, and energy metabolism. Specifically, while a high VitC/L-Pro ratio drives ESCs toward a naive state, the
opposite condition (L-Pro excess) captures a fully reversible early primed pluripotent state, which depends on autocrine fibroblast growth
factor and transforming growth factor b signaling pathways. Our findings highlight the pivotal role ofmetabolites availability in control-
ling the pluripotency continuum from naive to primed states.
INTRODUCTION
Pluripotency is transiently induced during the early stages
of mammalian embryo development. Blastocyst stem cells
progress from a ‘‘naive/ground’’ state to a ‘‘primed’’ state of
pluripotency before lineage commitment (Martinez Arias
et al., 2013). Two distinct pluripotent stem cells, embryonic
stem cells (ESCs) and epiblast stem cells (EpiSCs), are
considered as their in vitro counterparts. ESCs and EpiSCs
differ with respect to their morphology, metabolism,
DNAmethylation levels, transcription profiles, and growth
factors requirement (Weinberger et al., 2016). Pluripotency
states are unstable and thus difficult to stabilize in vitro.
Indeed, ESC cultures consist of heterogeneous cells dynam-
ically fluctuating between different pluripotent states (Hay-
ashi et al., 2008; Toyooka et al., 2008). EpiSCs frequently
lose the primed state, acquiring features of late pre-gastrula
embryos (Wu and Izpisua Belmonte, 2015). Known molec-
ular determinants of such plasticity are mainly transcrip-
tion factors, while the role of metabolism has been largely
unexplored until recently. Indeed, it has now become
evident that metabolites, including amino acids, act as
key regulators of pluripotent stem cell plasticity and
behavior. For instance, it has been shown that ESC self-
renewal depends on L-threonine (Wang et al., 2009), while
ESC identity is regulated by L-proline (L-Pro) availability
(Casalino et al., 2011; Comes et al., 2013; D’Aniello et al.,
2015; Washington et al., 2010). Moreover, several metabo-
lites act as epigenetic signals (Blaschke et al., 2013; Comes
et al., 2013; Shyh-Chang et al., 2012), thus defining a re-
gulatory network amongmetabolism, epigenetic modifica-
tion, and pluripotency, knowledge of which is still limited
(Harvey et al., 2016). Here we provide evidence that plurip-
otency is finely controlled by the mutual availability
of two physiological metabolites, vitamin C (VitC) and
L-Pro, and propose that naive and early primed pluripo-
tency states can be captured in vitro by exploiting the
epigenetic activity of these metabolites.
RESULTS
Vitamin C and L-Proline Induce Opposite Effects on
DNA Methylation in ESCs
Recent evidence from our laboratory demonstrates that
ESCs suffer a highly specific intrinsic shortage of the nones-
sential amino acid L-Pro, which induces the amino acid
stress response pathway (D’Aniello et al., 2015). Exoge-
nously provided L-Pro alleviates this stress condition and
converts round-shaped ESCs into flat-shaped pluripotent
stem cells. This phenotypic transition is fully reversible,
either after L-Pro withdrawal or by addition of VitC (Casa-
lino et al., 2011; Comes et al., 2013), raising the hypothesis
that these two metabolites play antagonistic roles in
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controlling ESC identity. VitC is the most relevant natu-
rally occurring reducing agent and enhances the catalytic
activity of 2-oxoglutarate/Fe(II)-dependent dioxygenases,
including TET DNA demethylases, and thereby contributes
to epigenetic regulation, cell differentiation, and reprog-
ramming (Hore et al., 2016; Krishnakumar and Blelloch,
2013; Monfort and Wutz, 2013). We thus reasoned that
VitC and L-Pro might regulate pluripotency by exerting
opposite effects on the dynamics of DNA methylation.
We first quantified DNAmethylation levels in ESCs treated
with L-Pro ±VitC at different time points by liquid chroma-
tography followed by mass spectrometry (LC-MS) (Figures
1A and 1B). VitC supplementation led to a rapid and sus-
tained increase of 5-hydroxymethylcytosine (5hmC) and
reduced 5-methylcytosine (5mC) levels. Conversely, sup-
plemental L-Pro increased 5mC and reduced 5hmC levels,
and its effect was fully counteracted by VitC (Figure 1B).
We then compared genome-wide methylation profiling of
ESCs ± L-Pro and ESCs, ±VitC, at days 2 and 5 of treatment.
Reduced representation bisulfite sequencing (RRBS) anal-
ysis identified 1,000 differentially methylated regions
(DMRs)distributed throughout all chromosomes (Figure1C
and Table S1). The methylation levels of individual CpGs
were highly correlated (r > 0.9) between the different
groups (Figures S1A and S1B). Interestingly, the majority
of DMRs (77% at day 2 and 96% at day 5) that were hypo-
methylated in VitC-treated ESCs were conversely hyperme-
thylated in L-Pro-treated ESCs (Figures 1D and S1C), thus
indicating that VitC and L-Pro modulate methylation at
the same DNA regions in an opposite manner. Of note, a
high fraction of DMRs (50%) lay in promoters (mostly
HCPs) and20% in enhancers (Figures S1D and S1E; Table
S1). Moreover, DMR-associated genes are highly enriched
in genes related to the developmental process (p = 6.3 3
1038) and DNA-binding transcriptional regulators (p =
9.7 3 1034) (Table S1). Our findings provide evidence
that L-Pro availability regulates DNA methylation in ESCs.
Of note, DNAmethylation levels increase in the transition
from naive to primed pluripotency (Maruotti et al., 2010),
thus leading to the hypothesis that the antagonistic effects
of VitC and L-Pro on the DNA methylation pattern might
regulate pluripotency.
Figure 1. Vitamin C and L-Proline Induce
Opposite Effects on DNA Methylation in
ESCs
(A) Schematic representation of the time-
course colony assay. FBS/LIF ESCs plated at
low density ± VitC (500 mM)/± L-Pro
(150 mM) for 5 days (left panel). Represen-
tative pictures of crystal violet-stained
colonies (right panels). Scale bars, 250 mm.
(B) Time-course mass spectrometry (MS)
analysis of 5hmc and 5mc levels in ESCs ±
VitC (500 mM)/± L-Pro (150 mM). Data are
relative levels (%) compared with day 1.
(C) Heatmap (CIMminer, http://discover.nci.
nih.gov/cimminer/) showing the differen-
tially methylated regions (DMRs) in ESCs ±
VitC (500 mM)/± L-Pro (150 mM) at days 2
and 5.
(D) Pie graphs showing the percentage of
DMRs shared by VitC- and L-Pro-treated ESCs
at days 2 and 5.
See also Figure S1.
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Vitamin C and L-Proline Modify mir-290/mir-302
Signature in ESCs
Pluripotent stem cell transition from naive to primed
state is marked by changes in the expression of the mir-
290 and mir-302 clusters, which correspond to naive (pre-
implantation epiblast) and primed (late post-implantation
epiblast of the pre-gastrulating embryo) states, respec-
tively; whereas co-expression of the two clusters identifies
an intermediate (early post-implantation epiblast) state
(Parchem et al., 2014). To assess whether VitC and L-Pro
impact on the expression of these microRNA clusters,
we exploited the potential of ESCs carrying the reporters
for the mir-290 and mir-302 loci (mir-290_mCherry/mir-
302_eGFP dual-reporter ESCs, named DRESCs) (Parchem
et al., 2014). Addition of VitC to fetal bovine serum
(FBS)/leukemia inhibitory factor (LIF) DRESCs increased
the fraction of mCherry+/eGFP (red) cells at the expense
of mCherry±/eGFP+ cells (yellow and green) (Figures 2A–
2C). A similar effect was observed in feeder-dependent
FBS/LIF culture conditions (Figures S2A–S2C). Conversely,
L-Pro supplementation increased the frequency of
mCherry+/eGFP+ (yellow) and mCherry/eGFP+ (green)
cells (Figures 2A–2C), and its effect was fully reversed by
VitC (Figures 2A–2C). Accordingly, the expression of all
members of the mir-302-367 cluster, and the pri-mir-302
was strongly induced in L-Pro-treated ESCs (Figures 2D,
Figure 2. Molecular and Pluripotency
Features of Vitamin C- and L-Proline-
Induced Cells
(A) Schematic representation of the experi-
mental strategy. Dual-reporter ESCs (DRESCs)
plated at low density ± VitC (500 mM)/±
L-Pro (150 mM) and analyzed at day 5.
(B) Representative bright-field and fluo-
rescence images of colonies generated from
DRESCs ± VitC (500 mM)/± L-Pro (150 mM) at
day 5. Red (mir-290), green (mir-302), and
yellow (mir-290 and mir-302) signals indi-
cate expression of the transgenes. Scale
bars, 250 mm.
(C) Fluorescence-activated cell sorting
(FACS) quantification of mCherry±/eGFP±
cells in DRESCs ± VitC (500 mM)/± L-Pro
(150 mM). Data are mean ± SEM; *p < 0.01
(n = 3 independent experiments).
(D) qPCR analysis of mir-302 expression in
L-Pro (150 mM) ± VitC (500 mM)-treated
ESCs at day 5. Data are fold change in gene
expression compared with control, normal-
ized to Gapdh, and are mean ± SEM; *p <
0.005 (n = 3 independent experiments).
(E) qPCR analysis of mir-290 expression in
L-Pro-treated ESCs (150 mM) at day 5. Data
are fold change versus control, normalized
to Gapdh, and are mean ± SEM (n = 3 inde-
pendent experiments).
(F) Representative pictures (left) and fre-
quency (right) of AP+, AP+/, and AP
staining on colonies derived from ESCs
plated at low density in the presence of the
indicated inhibitors, metabolites, and
growth factors. Data are mean ± SEM; *p <
0.05 (n = 3 independent experiments). Scale
bars, 250 mm.
(G) Principal component (PC) analysis of RNA-sequencing data generated from ESCs grown as indicated in (F).
(H) Representative pictures of bIII-tubulin (green) and GFAP (red) immunofluorescence on neurons derived from ESCs grown as in (F).
Nuclei are stained with DAPI. Scale bars, 100 mm.
See also Figure S2.
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Figure 3. L-Proline Mimics bFGF/Activin A Treatment in ESCs
(A and B) DRESCs were passaged three times in VitC (100 mM), plated at low density and treated with either L-Pro (1 mM) or F/A and
analyzed at days 3 and 5. Representative FACS plots (A, left panels) and quantification (A, right panel) of mCherry±/eGFP± cell distribution.
Quantification of eGFP intensity mean (B). Data are mean ± SEM; *p < 0.001 (n = 3 independent experiments).
(C) Schematic representation of eGFP/mCherry-positive cells’ distribution in colonies from L-Pro- and F/A-treated DRESCs.
(legend continued on next page)
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S2D, and S2E), whereas VitC blocked L-Pro-dependent in-
duction of mir-302 (Figure 2D). Of note, expression of
mir-290 cluster persisted, though to a reduced extent in
L-Pro-treated cells (Figure 2E). Our findings suggest that
FBS/LIF ESCs supplemented with either VitC or L-Pro
acquire a naive (mir-290+/mir-302) and a primed (mir-
290±/mir-302+) signature, respectively.
Molecular and Pluripotency Features of Vitamin
C- and L-Proline-Induced Cells
To further support our findings, we compared VitC- and
L-Pro-treated ESCs with naive/LIF/2i and primed/basic
fibroblast growth factor (bFGF)/Activin A (F/A) cells,
respectively. Interestingly, the percentage of round/
domed-shaped and alkaline phosphatase-positive (AP+)
colonies increased in 2i and VitC culture conditions
compared with control, which, as expected, showed some
irregular colonies with an intermediate AP staining
(AP+/) (Figure 2F). Conversely, flat-shaped F/A EpiSC col-
onies were AP negative. Interestingly, the large majority
(R90%) of L-Pro-induced flat-shaped colonies were either
AP+/ or AP (Figure 2F). To further investigate this pheno-
type, we compared the transcriptome profiling of FBS/LIF ±
VitC or L-Pro, naive/2i, and F/A EpiSCs, and identified
7,900 deregulated genes in the different conditions
(fold change [FC] R 2; p < 0.05). Interestingly, principal
component analysis placed VitC between 2i and untreated
control, and L-Pro between control and F/A (Figure 2G).
Accordingly, a set of pluripotency-associated genes was up-
regulated in 2i and VitC conditions but downregulated in
L-Pro and F/A compared with control. Conversely, priming
markers showed the opposite trend (Figure S2F and Table
S2). Consistent with these findings, the four cell popula-
tions significantly differ in their differentiation potential.
Indeed, only L-Pro- and F/A-derived neural cell populations
already showed complex bIII-tubulin+ structures at an early
time, and stained positive for the late glial marker glial fi-
brillary acidic protein (GFAP) (Figure 2H) (Fico et al.,
2008). These data suggest that VitC and L-Pro captured
alternative pluripotency states placed between the naive/
2i (Habibi et al., 2013) and primed/F/A.
L-Proline and F/A Capture Distinct Temporal Stages of
Primed Pluripotency
To further compare the effect of L-Pro and F/A, we analyzed
the distribution of mCherry±/eGFP± cells in VitC/DRESCs
upon treatment with either L-Pro or F/A. Interestingly,
mCherry+/eGFP+ (yellow) and mCherry/eGFP+ (green)
cells strongly and progressively increased in both L-Pro-
and F/A-treated ESCs at the expense of themCherry+/eGFP
(red) population (Figure 3A). However, the extent of L-Pro
and F/A activity was different. Specifically, the percentage
of mCherry/eGFP+ (green) cells almost doubled in F/A-
treated compared with L-Pro-treated cells and mCherry+/
eGFP (red) cells persisted, although at a low level, only in
L-Pro-treated DRESCs (day 5, Figure 3A). Furthermore,
eGFP fluorescence intensity was higher (4-fold) in F/A
comparedwith L-Pro (Figure 3B). In linewith these findings,
markers of the late epiblast (Brachyury, Cerberus, and Sox17)
were induced by L-Pro, although at lower levels compared
with F/A (Figure S3A). Finally, although the fraction of
mCherry+/eGFP+ (yellow) cells was comparable, the mir-
302/mir-290 expression ratio was 10-fold higher in F/A
compared with L-Pro (Figure S3B). To further explore the
possibility that L-Pro and F/A induced distinct temporal
stages of primed pluripotency, we compared the transcrip-
tome profiling of the L-Pro and F/A mCherry+/eGFP+
(yellow) population, and found >1,000 genes deregulated
comparedwithmCherry+/eGFP (red) control cells (NoiSeq;
posterior probability > 0.99; FC R 4; Table S3). The two
populations shared up to 75% of common genes (Fig-
ure 3D) with the same deregulation trend (Figure 3E) but
(D) Venn diagram showing the overlap between differentially expressed genes in mCherry+/eGFP+ (yellow) cells from L-Pro-treated (day 5)
and F/A-treated (days 3 and 5) DRESCs. Relative expression of each gene was normalized to untreated cells.
(E) Heatmap representation of genes deregulated in L-Pro-treated (day 5) and F/A-treated (days 3 and 5) cells compared with control.
(F) Western blot analysis of phospho-Erk/Erk (upper panels) and phospho-Smad2/Smad2 (lower panels) in L-Pro-induced cells (PiCs)
treated with ±bFGF (12 ng/mL) and ±Activin A (20 ng/mL) (15 min), respectively. Anti-Gapdh antibody was used as loading control.
Densitometric analysis (arbitrary densitometry units [ADU]) is shown as pErk/Erk and pSmad2/Smad2 ratio. Data are mean ± SEM;
*p < 0.01 (n = 3 independent experiments).
(G) Projection to latent structure-discriminant analysis (PLS-DA) score plot showing the projection of all the spectral classes analyzed
(L-Pro, green boxes; and +L-Pro, red boxes). The model quality is evaluated by the goodness of fit and the goodness of prediction,
represented by parameters R2Y = 0.98 and Q2 = 0.96. Classes are separated along the first principal component t[1], which represents
interclass variation. The second component t[2] accounts for intraclass variation.
(H) Schematic representation of the oxidative phosphorylation (blue) and glycolysis (red) metabolic pathways.
(I) Representative phase-contrast images of ESC and PiC colonies (day 5), and ±2-DG (50 mM; 16 hr), stained with crystal violet. Scale
bars, 200 mm.
(J) Tetramethylrhodamine (TMRE) mean intensity in ESCs, EpiSCs, and PiCs at day 5. Data are mean ± SEM; *p < 0.05 (n = 3 independent
experiments).
See also Figure S3.
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different magnitudes. Specifically, pluripotency-associated
genes were downregulated either at similar level (Nanog,
Klf2, Klf4, and Gbx2) or at lower levels (up to 10-fold)
(Dppa 2, 3, 4, 5a, Rex1, Esrrb) in F/A- compared with L-Pro-
treated cells (Figure S3C and Table S3). Furthermore, mesen-
dodermal-related genes (e.g., Brachyury, Cer1, Dkk1, Eomes,
Foxa2, and Sox17) were induced at higher levels in F/A
than in L-Pro (Figure S3D and Table S3). We then asked
whether L-Pro-induced cells (PiCs) were still responsive to
F/A. Both Erk and Smad2 phosphorylation was induced in
PiCs upon addition of either bFGF or activin (Figure 3F),
andmCherry+/eGFP+ (yellow) andmCherry/eGFP+ (green)
cells increased at the expense ofmCherry+/eGFP (red) cells
(Figure S3E). In addition, mean eGFP intensity also
increased in F/A-treated PiCs (Figure S3E). These data indi-
cate that L-Pro and F/A similarly induce a naive to primed
transition and further suggest that L-Pro captures an earlier
primed state.
L-Proline Induces aMetabolic Reprogramming in ESCs
One of the earliest events that occur in the transition
from naive to primed pluripotency is a switch from a
bivalent to exclusively glycolytic metabolism (Zhou
et al., 2012). We thus performed a nuclear magnetic
resonance (NMR)-based global metabolomic profiling of
ESCs ± L-Pro and found strong differences in their
metabolite content (Figure 3G and Table S4). In particular,
PiCs showed increased levels of L-Pro and reduced levels of
different amino acids (L-Gln, L-Tyr, L-Gly, L-Ala L-Val,
L-Leu, L-Ser) (Table S4), in line with our previous find-
ings that L-Pro supplementation inactivates the amino
acid stress response pathway in ESCs (D’Aniello et al.,
2015). Remarkably, lactate levels significantly increased
(Figures 3G, 3H, and S3F; Table S4) and PiCs were more
susceptible to the glycolysis inhibitor 2-deoxy-D-glucose
(2-DG) compared with ESCs (Figures 3H, 3I, and S3G),
suggesting a metabolic shift to glycolysis. Moreover, the
mitochondrial membrane potential was significantly
reduced in PiCs as in F/A EpiSCs compared with ESCs (Fig-
ure 3J), indicating that oxidative phosphorylation was
reduced, and further supporting the idea that PiCs un-
dergo a metabolic reprogramming, which resembles the
one occurring in the naive to primed transition (Zhou
et al., 2012).
L-Proline-Induced Primed State Depends on Autocrine
FGF and TGF-b Signaling Pathways
To further explore the notion that L-Pro and F/A exert
similar effects on ESCs, we first evaluated whether L-Pro
induced Erk (FGF) and Smad2 (transforming growth
factor b [TGF-b]) signaling pathways in FBS/LIF ESCs. Inter-
estingly, both Erk and Smad2 phosphorylation were
induced by supplemental L-Pro (Figure 4A). Furthermore,
L-Pro-induced phenotypic transition was impaired in
the presence of FGF and TGF-b chemical inhibitors
PD0325901 and SB431542, respectively. Indeed, while
L-Pro-treated cells generated only 15% of domed colonies,
domed-shaped mCherry+/eGFP (red) colonies increased
up to 70% in the presence of PD0325901 or SB431542,
even with high doses of L-Pro (Figures 4B and 4C). More-
over, gene ontology analysis revealed that the transcrip-
tome of both L-Pro- and F/A-derived mCherry+/eGFP+
(yellow) cellswashighly enriched ingenesof Erk superpath-
way (Figures 4D and 4E; Table S3). These data suggested
that L-Pro drives naive ESCs toward a primed state of plurip-
otency by inducing and sustaining autocrine FGF and
TGF-b signaling.
DISCUSSION
The naive to lineage primed transition was proposed as a
gradual continuumof pluripotent states with distinct func-
tional and transcriptional signatures and biases (Tesar,
2016). Several stem cell types with different degrees of plu-
ripotency can be established under artificial culture condi-
tions (Wu and Izpisua Belmonte, 2015). Specifically, naive
and primed (EpiSCs) cells rely on chemical inhibitors (2i) or
growth factors (F/A), respectively, and are largely used as
in vitro models of pluripotency. Here we provide evidence
that the relative levels of two physiological metabolites,
namely VitC and L-Pro, push FBS/LIF ESCs toward naive
(low L-Pro/high VitC) or early primed (high L-Pro/low
VitC) states, between naive/2i and F/A primed states of
the pluripotency continuum. In particular, similarly to
the F/A primed state (EpiSCs), the high L-Pro/low VitC con-
dition is associated with a metabolic reprogramming to-
ward glycolysis and is strictly dependent on the activation
and maintenance of autocrine bFGF and TGF-b signaling
pathways. Interestingly, while F/A EpiSCs show molecular
features of late pre-gastrulation epiblast and are difficult
to revert to naive ESCs (Guo et al., 2009), PiCs display mo-
lecular, metabolic, and functional features (Table S5) of a
transitional/reversible primed state in the pluripotency
continuum, which has been hypothesized to define the
boundary beyond which the transition becomes irrevers-
ible (Hackett and Surani, 2014; Martello and Smith,
2014). Of note, our findings indicate that VitC and L-Pro
are both limiting in ESCs even in complete FBS/LIF culture
conditions. This is in line with our recent findings that an
autoregulatory loop limits L-Pro biosynthesis in ESCs
(D’Aniello et al., 2015); nevertheless, whether and how
intracellular levels of VitC are regulated in ESCs is still un-
known and deserves further investigation. VitC enhances
epigenetic modifications, including DNA and histone de-
methylation, and promotes cell reprogramming (Esteban
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et al., 2010; Stadtfeld et al., 2012; Wang et al., 2011). Here
we show that VitC and L-Pro supplementation oppositely
modify DNA methylation at genomic regions that nor-
mally gain methylation during the blastocyst to epiblast
transition (Blaschke et al., 2013). The DNA demethylation
effect of VitC is well explained by its ability to positively
regulate Fe(II)/oxoglutarate-dependent dioxygenase en-
zymes of the TET family (5mC to 5hmC conversion)
(Blaschke et al., 2013; von Meyenn et al., 2016).
Conversely, no data have been reported so far linking
L-Pro and DNA methylation. Although the molecular
mechanism by which a sudden increase of L-Pro induces
DNA methylation in ESCs is still far from being fully eluci-
dated, we suggest that L-Pro may influence VitC homeosta-
sis, reducing its availability/activity for the TET demethy-
lases. First, the vast majority of the genomic regions that
are hypomethylated in VitC-treated ESCs are in turn hyper-
methylated upon L-Pro supplementation. Moreover, at
appropriate stoichiometric ratios, VitC fully counteracts
L-Pro-induced DNA methylation. How may L-Pro affect
VitC availability? L-Pro could alter the redox balance and
eventually induce VitC oxidation, i.e., its conversion to de-
hydroascorbic acid, by generating reactive oxygen species,
which are by-product of the activity of mitochondrial L-Pro
oxidase enzyme (PRODH/POX) (Phang et al., 2010). How-
ever, previous findings argue against a primary role of
oxidative stress/redox signaling in this process (Comes
et al., 2013; D’Aniello et al., 2015), and further evidence
comes from metabolomics analysis, which reveals no sign
of global oxidation and even higher levels of reduced gluta-
thione (GSH) in L-Pro-treated cells (Figure 3G and Table S4),
suggesting that L-Pro supplementation does not exert an
Figure 4. L-Proline Induces FGF and TGF-b
Signaling in ESCs
(A) Western blot analysis of phospho-Erk/Erk
(upper panels) and phospho-Smad2/Smad2
proteins (lower panels) in ESCs ± L-Pro
(1 mM; 20 hr). Anti-Gapdh antibody was used
as loading control. Densitometric analysis
(ADU) is shown as pErk/Erk and pSmad2/
Smad2 ratio. Data are mean ± SEM; *p < 0.05
(n = 3 independent experiments).
(B) Representative photomicrographs (upper
panels) of colonies generated from ESCs ±
L-Pro, either alone or ±PD0325901 (PD,
1–3 mM) or SB431542 (SB, 10–20 mM), and
stained with crystal violet. Scale bars,
250 mm. Classification of colonies based on
their morphology (lower panel). Data are
mean ± SEM; *p < 0.01 (n = 3 independent
experiments).
(C) Representative images of mCherry+ col-
onies generated from ESCs ± L-Pro (1 mM),
either alone or ±PD or SB, at day 5. Scale
bars, 250 mm.
(D) Transcriptome analysis using GeneAna-
lytics software showing the enrichment in Erk
pathway-associated genes in L-Pro- and FA-
treated cells (day 5).
(E) Heatmap showing Erk-superpathway-
related genes deregulated in L-Pro-treated
(day 5) and F/A-treated (days 3 and 5) ESCs.
See also Figure S3.
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oxidizing effect in these culture conditions. Thus, we pro-
pose that the mechanism by which VitC and L-Pro antago-
nistic effects capture alternative states in the pluripotency
continuum does not rely, at least primarily, on altered
redox balance, which would favor a reducing (VitC) versus
an oxidant (L-Pro) state. Of note, this is consistent with the
idea that pluripotency is linked to a reduced state, while
activation of oxidation is a metabolic signature of ESC dif-
ferentiation (Yanes et al., 2010). Indeed, the GSH/gluta-
thione disulfide (GSSG) ratio and VitC levels are inversely
correlated in ESC cardiac and neural differentiation, sug-
gesting that VitC compensates for GSSG accumulation to
maintain homeostasis (Yanes et al., 2010). Since L-Pro activ-
ity depends on protein synthesis (D’Aniello et al., 2015), we
hypothesize that a sudden increase of L-Pro could influence
VitC homeostasis/availability, at least in part, by inducing
the synthesis of L-Pro-rich proteins such as collagens.
Indeed, nascent collagens are modified by VitC-dependent
Fe(II)/oxoglutarate-dependent prolyl hydroxylase enzymes
(Gorres and Raines, 2010). Thus, an abrupt increment of
collagen biosynthesis/hydroxylation may reduce VitC
availability for TET demethylases as well as for other
VitC-dependent enzymes, such as the prolyl hydroxylases
that regulate the hypoxia-inducible factor (HIF) steady-
state level (Fong and Takeda, 2008). Interestingly, HIF is a
key regulator of the metabolic reprogramming and is stabi-
lized in primed but not in naive human ESCs (Sperber et al.,
2015; Zhou et al., 2012). Of note, some of the HIF targets
are induced in L-Pro-treated cells, such as Ldha, Pfkfb3,
Plin2, Gbe1, and Pygl (Table S2). Although future studies
are needed to clarify the molecular mechanisms, our find-
ings have important implications for stem cell biology as
they provide insights into how the availability of natural
metabolites contribute to global epigenetic changes regu-
lating alternative pluripotent states (Carey et al., 2015;
Ryall et al., 2015; Wang et al., 2009). Furthermore, they
attest to the definition of the optimal culture conditions
for the capture in vitro of an early primed state of
pluripotency.
EXPERIMENTAL PROCEDURES
Full details of the Experimental Procedure are included in Supple-
mental Experimental Procedures.
Culture of ESCs, Reagents, and Treatments
Wild-type TBV2 (129/SvP) and dual-reporter (DRESCs)mouse ESCs
weremaintained on a feeder layer ofmitomycinC-treatedMEFs ac-
cording to standard procedures. ESC to PiC transition and ESC to
EpiSC transition were performed as previously described (Casalino
et al., 2011; Guo et al., 2009).
VitC was dissolved in water and used at the indicated concen-
trations (100–500 mM). VitC/L-Pro were added concomitantly.
PD0325901 and SB431542 (Sigma-Aldrich) were used at concen-
tration ranging from 1 to 3 mM and 10 to 20 mM, respectively.
2-Deoxy-D-glucose (2-DG, Sigma-Aldrich) was dissolved in water
and used at concentration ranging from 6.25 to 50 mM.
5mC and 5hmC HPLC-MS/MS Measurement
Genomic DNA was extracted using the Wizard Genomic DNA
Purification kit (Promega). 5mC and 5hmC high-performance
liquid chromatography (HPLC)-tandem MS measurements were
performed as described previously (Kroeze et al., 2014).
RNA Sequencing andReduced Representation Bisulfite
Sequencing
RNA sequencing and RRBS were performed at the Institute of
Applied Genomics (Udine, Italy).
NMR-Based Metabolomic Analysis
The metabolic profiles were acquired through NMR spectroscopy.
Details on data processing are provided in Supplemental Experi-
mental Procedures.
Statistical Analysis
Statistical significance was determined by a two-tailed paired
Student’s t test. p Values of <0.05 were considered as statistically
significant. Error bars in the figures represent SEM.
Multivariate statistical analysis of NMR data was performed us-
ing SIMCA 14 software (Umetrics). Details are provided in Supple-
mental Experimental Procedures.
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SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
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